CytoMed Therapeutics Limited (GDTC)

NASDAQ: GDTC · Real-Time Price · USD

1.020

+0.030 (3.03%)

At close: Jun 26, 2026, 4:00 PM EDT

1.010

-0.010 (-0.98%)

After-hours: Jun 26, 2026, 6:59 PM EDT

CytoMed Therapeutics Balance Sheet

Financials in millions SGD. Fiscal year is January - December.

Millions SGD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2.1	4.97	9	1.58	2.51
Cash & Short-Term Investments	2.1	4.97	9	1.58	2.51
Cash Growth	-57.84%	-44.74%	469.41%	-37.13%	183.84%
Accounts Receivable	1.57	1.03	1.1	-	-
Other Receivables	-	-	-	0.91	0.77
Total Trade Receivables	1.57	1.03	1.1	0.91	0.77
Total Current Assets	3.66	6	10.1	2.49	3.28
Net Property, Plant & Equipment	3.69	3.25	2.06	2.47	2.5
Other Intangible Assets	0.12	0.09	0.01	0.02	0.03
Long-Term Investments	0.02	0.22	0.2	0.24	0.27
Other Long-Term Assets	0.49	0.5	-	-	-
Total Assets	7.98	10.07	12.37	5.23	6.08
Accounts Payable	0.44	0.44	0.52	0.42	0.22
Short-Term Debt	-	-	-	3.4	2.31
Current Portion of Long-Term Debt	0.04	0.04	0.03	0.33	0.39
Current Portion of Leases	0.02	0.01	0.01	0.01	0.01
Unearned Revenue	0.18	0.11	0.01	0	0.01
Other Current Liabilities	0.03	0.01	0.15	0	-
Total Current Liabilities	0.71	0.61	0.72	4.17	2.94
Long-Term Debt	0.37	0.39	0.41	0.47	0.54
Long-Term Leases	0.05	0.02	-	0.01	0.02
Total Long-Term Liabilities	0.42	0.42	0.41	0.48	0.55
Total Liabilities	1.13	1.02	1.12	4.64	3.49
Common Stock	24.66	23.79	23.72	8.91	6.55
Additional Paid-in Capital	0.64	0.07	0.07	-	1.14
Accumulated Other Comprehensive Income	0.08	-0.05	-0.22	-0.13	-0.03
Retained Earnings	-18.83	-14.85	-12.33	-8.2	-5.07
Total Common Shareholders' Equity	6.54	8.97	11.25	0.59	2.59
Minority Interest	0.31	0.08	-0	-0	-0
Shareholders' Equity	6.85	9.04	11.24	0.59	2.59
Total Liabilities & Equity	7.98	10.07	12.37	5.23	6.08
Total Debt	0.48	0.46	0.45	4.22	3.26
Net Cash (Debt)	1.61	4.51	8.55	-2.64	-0.75
Net Cash Growth	-64.21%	-47.27%	-	-	-
Net Cash Per Share	0.14	0.39	0.80	-0.33	-0.09
Book Value	6.54	8.97	11.25	0.59	2.59
Book Value Per Share	0.56	0.78	1.06	0.07	0.33
Tangible Book Value	6.42	8.87	11.23	0.57	2.56
Tangible Book Value Per Share	0.55	0.77	1.06	0.07	0.32

SEC Filings: 10-K · 10-Q